La marque MAPP Multinational Assessment of Psoriasis and Psoriatic Arthritis Navigating the Course of Psoriatic Disease, fondée en 2013 (États-Unis), a 126 marques sœurs et 17477 marques concurrentes. La marque MAPP Multinational Assessment of Psoriasis and Psoriatic Arthritis Navigating the Course of Psoriatic Disease est détenue par Celgene, société cotée à New York. MAPP Multinational Assessment of Psoriasis and Psoriatic Arthritis Navigating the Course of Psoriatic Disease fait partie du secteur d’activité Fabricants de médicaments.
L'actualité de la marque MAPP Multinational Assessment of Psoriasis and Psoriatic Arthritis Navigating the Course of Psoriatic Disease
Derniers Tweets
Celgene
(MAPP Multinational Assessment of Psoriasis and Psoriatic Arthritis Navigating the Course of Psoriatic Disease)
.
Toute l'actualité 
Celgene
(MAPP Multinational Assessment of Psoriasis and Psoriatic Arthritis Navigating the Course of Psoriatic Disease)
Derniers Tweets
Celgene
(MAPP Multinational Assessment of Psoriasis and Psoriatic Arthritis Navigating the Course of Psoriatic Disease)
.
Bourse : Plus d'information sur Celgene
(MAPP Multinational Assessment of Psoriasis and Psoriatic Arthritis Navigating the Course of Psoriatic Disease)
